Evidence map›Paper›PMID 42243545›Full record

ArticleMolecular systems biology2026

Active learning-guided mechanistic modeling reveals context-specific regulators of CXCL9 expression in pancreatic cancer cells.

Bi-Rong Wang, Maaruthy Yelleswarapu, Lucie Descamps, Federica Eduati

Abstract read
In one paragraph

Article in Molecular systems biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Bi-Rong WangDepartment of Biomedical Engineering, Eindhoven University of Technology, PO Box 513, Eindhoven, 5600MB, the Netherlands.ORCID http://orcid.org/0009-0003-1560-8852
Maaruthy YelleswarapuDepartment of Biomedical Engineering, Eindhoven University of Technology, PO Box 513, Eindhoven, 5600MB, the Netherlands.
Lucie DescampsDepartment of Biomedical Engineering, Eindhoven University of Technology, PO Box 513, Eindhoven, 5600MB, the Netherlands.ORCID http://orcid.org/0000-0003-2342-2532
Federica EduatiDepartment of Biomedical Engineering, Eindhoven University of Technology, PO Box 513, Eindhoven, 5600MB, the Netherlands. f.eduati@tue.nl.ORCID http://orcid.org/0000-0002-7822-3867

Funding

Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO) 015.021.065Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO) 24.005.009
6 · The paper itself

Abstract

Cold tumors like pancreatic cancer suffer from poor immune infiltration, limiting effective anti-tumor responses. The chemokine CXCL9 promotes immune cell recruitment, but the signaling mechanisms regulating its expression in tumor cells remain poorly understood and underexplored as targets for modulation. We present a framework that integrates active learning with mechanistic logic-ODE models to guide perturbation screenings and uncover regulators of CXCL9 in pancreatic cancer cells. Using perturbation-response data and curated prior knowledge, we trained interpretable models to identify signaling mechanisms that enhance CXCL9 expression and prioritize drug combinations. Active learning enabled data-efficient model refinement and guided informative experiments under resource constraints. Benchmarking on synthetic data and experimental validation confirmed the performance of different acquisition strategies and its applicability to feasible iterative wet lab experiments. Our results demonstrate how combining active learning with mechanistic modeling supports rational, targeted experimental design.

Indexed as

Chemokine CXCL9Pancreatic NeoplasmsCell Line, TumorGene Expression Regulation, NeoplasticHumansMachine LearningSignal TransductionChemokine CXCL9CXCL9 protein, human

Identifiers

PMID42243545
PMCPMC13434641

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.